XOSPATA is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test
XOSPATA (gilteritinib) tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in India - Gurgaon, Mumbai, Delhi, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, and Surat. To inquire about the cost price of purchasing XOSPATA and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
If the Brand Name medication "XOSPATA (gilteritinib) tablets" is not approved or unavailable in your country, patients, physicians, and distributors/suppliers have the option to purchase and import it from Verve Biosciences. To begin the process, you can make an enquiry, and we will assist you in calculating the total cost to buy "XOSPATA (gilteritinib) tablets" online and arrange delivery to your location. To proceed, we will require a prescription from your treating doctor, and in certain countries, an import license may also be necessary. Throughout the process, our Patient Support team will provide guidance and support.
Verve Biosciences offers assistance in importing the anti-cancer medication XOSPATA (gilteritinib) tablets. To inquire about the total cost of XOSPATA (gilteritinib) tablets in various countries, including UAE, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, as well as Europe (such as UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithania, Greece, Spain, Maldova, Germany, Sweden, Italy, Bulgaria, Romania, Montenegro, Russia), and other countries like Zimbabwe, Australia, and New Zealand, please reach out to us. We will provide you with the necessary information regarding the pricing and availability of XOSPATA (gilteritinib) tablets in the desired locations.